Hjem › Myelodysplastiske syndromer › Illinois › Springfield
Kliniske studier for Myelodysplastiske syndromer i Springfield, IL
3 studier for Myelodysplastiske syndromer søker deltakere på steder i og rundt Springfield (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Southern Illinois University School of Medicine, Springfield
Myelodysplastiske syndromer-studier i andre byer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Boston, MA19 studier
- Tampa, FL19 studier
- Miami, FL17 studier
- Columbus, OH14 studier
- Durham, NC14 studier
- Chicago, IL13 studier
- Atlanta, GA13 studier
Andre studier i Springfield
- Ikke-småcellet lungekreft13 studier
- Lungekreft12 studier
- Kolorektal kreft9 studier
- Akut myelogen leukemi8 studier
- Brystkreft8 studier
- Plateepitelcancer i hode og hals6 studier
- Nyrekreft (nyrecellekarcinom)6 studier
- Prostatakreft6 studier
- Kreft (alle typer)6 studier
- Blærekreft6 studier
- Pankreaskreft5 studier
- Melanom5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.